Major SONM holder DNA Holdings Venture reports 223,201 shares

Rhea-AI Filing Summary

DNA X, Inc. large shareholder DNA Holdings Venture Inc. filed an initial ownership report showing direct holdings of 223,201 shares of Common Stock. This Form 3 establishes that DNA Holdings Venture Inc. is a more than ten percent owner of DNA X, Inc. as of the reported date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider DNA Holdings Venture Inc.

Role 10% Owner

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 223,201 shares (Direct)

Footnotes (1)

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

DNA Holdings Venture Inc.

(Last) (First) (Middle)

151 CALLE DE SAN FRANSICO, STE 200

(Street)

SAN JUAN PR 00901-1607

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/15/2025

3. Issuer Name and Ticker or Trading Symbol
DNA X, Inc. [ SONM ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	223,201	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ DNA Holdings Venture Inc., By: Scott Walker, Chairman	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does DNA Holdings Venture Inc. report on its Form 3 for SONM?

DNA Holdings Venture Inc. reports that it directly owns 223,201 shares of Common Stock of DNA X, Inc.. This initial Form 3 filing establishes its status as a more than ten percent beneficial owner of the company’s stock.

Is DNA Holdings Venture Inc. a director or officer of DNA X, Inc. (SONM)?

No, DNA Holdings Venture Inc. is not listed as a director or officer of DNA X, Inc. It is identified solely as a more than ten percent owner, based on its reported holdings of 223,201 common shares.

How many SONM shares does DNA Holdings Venture Inc. own according to this filing?

DNA Holdings Venture Inc. reports 223,201 shares of Common Stock owned directly following the reported holdings entry. This number reflects its total direct beneficial ownership as disclosed in the Form 3 insider ownership statement for DNA X, Inc.

Does this Form 3 for SONM show any recent insider share purchases or sales?

No specific purchases or sales are identified; the Form 3 reflects holdings rather than a buy or sell transaction. It records DNA Holdings Venture Inc.’s ownership of 223,201 common shares, establishing baseline insider ownership information for regulatory reporting.

What type of security is reported by DNA Holdings Venture Inc. in SONM?

The filing reports ownership of Common Stock of DNA X, Inc. DNA Holdings Venture Inc. shows total direct holdings of 223,201 common shares, confirming its position as a significant, more than ten percent beneficial owner of this equity security class.

Is DNA Holdings Venture Inc.’s ownership in SONM direct or indirect?

The Form 3 classifies DNA Holdings Venture Inc.’s interest as direct ownership, using the code “D.” This indicates that the 223,201 common shares are held directly in its name, rather than through an intermediary entity or indirect structure.